Pieter Cullis, visionary NanoVation Therapeutics^TM Board Chair and co-founder, is the keynote speaker at the MSKCC’s Molecular Pharmacology and Chemical Biology Research Seminar Series in New York.

Don’t miss his insights on the “Design of Lipid Nanoparticles for Enabling Gene Therapies” on March 12th @ 4:00 pm